BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 31596734)

  • 1. The long non-coding RNA, urothelial carcinoma associated 1, promotes cell growth, invasion, migration, and chemo-resistance in glioma through Wnt/β-catenin signaling pathway.
    Zhang B; Fang S; Cheng Y; Zhou C; Deng F
    Aging (Albany NY); 2019 Oct; 11(19):8239-8253. PubMed ID: 31596734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway.
    Liu H; Wang G; Yang L; Qu J; Yang Z; Zhou X
    PLoS One; 2016; 11(12):e0168406. PubMed ID: 27977766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
    Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A positive feedback loop of lncRNA-RMRP/ZNRF3 axis and Wnt/β-catenin signaling regulates the progression and temozolomide resistance in glioma.
    Liu T; Hu J; Han B; Tan S; Jia W; Xin Y
    Cell Death Dis; 2021 Oct; 12(11):952. PubMed ID: 34657141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA SUMO1P3 promotes glioma progression via the Wnt/β-catenin pathway.
    Lou JY; Luo J; Yang SC; Ding GF; Liao W; Zhou RX; Qiu CZ; Chen JM
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9571-9580. PubMed ID: 33015800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
    Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
    Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA ASB16-AS1 enhances cell proliferation, migration and invasion via functioning as a ceRNA through miR-1305/Wnt/β-catenin axis in cervical cancer.
    Liu W; Zhuang R; Feng S; Bai X; Jia Z; Kapora E; Tan W
    Biomed Pharmacother; 2020 May; 125():109965. PubMed ID: 32058219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA UCA1 contributes to the progression of oral squamous cell carcinoma by regulating the WNT/β-catenin signaling pathway.
    Yang YT; Wang YF; Lai JY; Shen SY; Wang F; Kong J; Zhang W; Yang HY
    Cancer Sci; 2016 Nov; 107(11):1581-1589. PubMed ID: 27560546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA H19 regulates the development of gliomas through the Wnt/β-catenin signaling pathway.
    Guan N; Wang R; Guo WS; Lai YJ; Zhang YD; Cheng YY
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4243-4253. PubMed ID: 31173296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YY1-Induced Upregulation of Long Noncoding RNA ARAP1-AS1 Promotes Cell Migration and Invasion in Colorectal Cancer Through the Wnt/β-Catenin Signaling Pathway.
    Ye Y; Gu B; Wang Y; Shen S; Huang W
    Cancer Biother Radiopharm; 2019 Oct; 34(8):519-528. PubMed ID: 31173500
    [No Abstract]   [Full Text] [Related]  

  • 11. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA UCA1 inhibits esophageal squamous-cell carcinoma growth by regulating the Wnt signaling pathway.
    Wang X; Gao Z; Liao J; Shang M; Li X; Yin L; Pu Y; Liu R
    J Toxicol Environ Health A; 2016; 79(9-10):407-18. PubMed ID: 27267823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA UCA1 sponges miR-204-5p to promote migration, invasion and epithelial-mesenchymal transition of glioma cells via upregulation of ZEB1.
    Liang C; Yang Y; Guan J; Lv T; Qu S; Fu Q; Zhao H
    Pathol Res Pract; 2018 Sep; 214(9):1474-1481. PubMed ID: 30107990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of Urothelial Carcinoma-Associated 1 Suppressed Cell Growth and Migration Through Regulating miR-301a and CXCR4 in Osteosarcoma MHCC97 Cells.
    Zhu G; Liu X; Su Y; Kong F; Hong X; Lin Z
    Oncol Res; 2018 Dec; 27(1):55-64. PubMed ID: 29523218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
    Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
    Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7.
    Yue X; Cao D; Lan F; Pan Q; Xia T; Yu H
    Neuro Oncol; 2016 Sep; 18(9):1288-96. PubMed ID: 27006177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHCBP1 promotes cisplatin induced apoptosis resistance, migration and invasion through activating Wnt pathway.
    Zou A; Wu A; Luo M; Zhou C; Lu Y; Yu X
    Life Sci; 2019 Oct; 235():116798. PubMed ID: 31472149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
    Xia S; Ji R; Zhan W
    BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA LINC01503 predicts worse prognosis in glioma and promotes tumorigenesis and progression through activation of Wnt/β-catenin signaling.
    Wang H; Sheng ZG; Dai LZ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1600-1609. PubMed ID: 30840283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA UCA1 promotes cell proliferation, invasion and migration of laryngeal squamous cell carcinoma cells by activating Wnt/β-catenin signaling pathway.
    Sun S; Gong C; Yuan K
    Exp Ther Med; 2019 Feb; 17(2):1182-1189. PubMed ID: 30679991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.